AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Financials
AGMB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 332.0 million | 29.2 million |
| March 31, 2026 | 189.8 million | 21.4 million |
| Dec. 31, 2025 | 180.4 million | 26.8 million |
| Sept. 30, 2025 | 194.4 million | 21.9 million |
AGMB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -14.7 million | 571834 |
| Dec. 31, 2025 | -15.5 million | 1.7 million |
| Sept. 30, 2025 | -16.0 million | 1.6 million |
AGMB Net Income
No data available :(
AGMB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 287.6 million | - | 1.3 million |
| March 31, 2026 | 148.5 million | - | - |
| Dec. 31, 2025 | 136.8 million | - | 1.5 million |
| Sept. 30, 2025 | 152.1 million | - | 1.6 million |
AGMB Shares Outstanding
AGMB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | - | - | - |
| March 31, 2026 | 415983 | 12.3 million | 1.6 million | - |
| Dec. 31, 2025 | 4695 | 16.3 million | 3.8 million | - |
| Sept. 30, 2025 | - | 15.2 million | 3.1 million | - |
AGMB Cost of Revenue
No data available :(
AGMB
Price: $8.81
52 week price:
Earnings Per Share: -1.57 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 428.0 million